EA201991819A1 - Пастилка - Google Patents

Пастилка

Info

Publication number
EA201991819A1
EA201991819A1 EA201991819A EA201991819A EA201991819A1 EA 201991819 A1 EA201991819 A1 EA 201991819A1 EA 201991819 A EA201991819 A EA 201991819A EA 201991819 A EA201991819 A EA 201991819A EA 201991819 A1 EA201991819 A1 EA 201991819A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pastilka
lozenge
excipients
treating
well
Prior art date
Application number
EA201991819A
Other languages
English (en)
Other versions
EA039362B1 (ru
Inventor
Кристина Тюрессон
Карина Сиверссон
Микаэль Бисрат
Катарина Линделль
Original Assignee
Джонсон энд Джонсон Консьюмер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джонсон энд Джонсон Консьюмер Инк. filed Critical Джонсон энд Джонсон Консьюмер Инк.
Publication of EA201991819A1 publication Critical patent/EA201991819A1/ru
Publication of EA039362B1 publication Critical patent/EA039362B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к пастилке, содержащей микронизированный бензокаин, по меньшей мере один усилитель растворения и один или более эксципиентов, а также к применению пастилки для лечения боли в горле.
EA201991819A 2017-02-01 2018-01-31 Пастилка EA039362B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1750079 2017-02-01
PCT/US2018/016062 WO2018144491A1 (en) 2017-02-01 2018-01-31 A lozenge

Publications (2)

Publication Number Publication Date
EA201991819A1 true EA201991819A1 (ru) 2020-01-14
EA039362B1 EA039362B1 (ru) 2022-01-18

Family

ID=61224571

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991819A EA039362B1 (ru) 2017-02-01 2018-01-31 Пастилка

Country Status (12)

Country Link
US (2) US11400047B2 (ru)
EP (2) EP3915540A1 (ru)
AU (1) AU2018216886B2 (ru)
CA (1) CA3050738A1 (ru)
DK (1) DK3576718T3 (ru)
EA (1) EA039362B1 (ru)
ES (1) ES2881482T3 (ru)
HR (1) HRP20211247T1 (ru)
HU (1) HUE055173T2 (ru)
PL (1) PL3576718T3 (ru)
PT (1) PT3576718T (ru)
WO (1) WO2018144491A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018144491A1 (en) * 2017-02-01 2018-08-09 Johnson & Johnson Consumer Inc. A lozenge
EP4200026A1 (en) * 2021-04-23 2023-06-28 Colgate-Palmolive Company Solid oral care compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511914A (en) 1967-01-31 1970-05-12 Schering Corp Throat lozenge vehicle
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
WO2001019329A2 (en) 1999-09-11 2001-03-22 The Procter & Gamble Company Polyoxyalkylene copolymers containing pourable liquid vehicles
US20100010101A1 (en) * 2000-07-05 2010-01-14 Capricorn Pharma, Inc. Rapid-Melt Compositions and Methods of Making Same
US8980334B2 (en) 2001-02-28 2015-03-17 Axiomedic Ltd. Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
US20050008704A1 (en) * 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
US20050152972A1 (en) 2004-01-14 2005-07-14 Mohinder Singh Soft chewable anesthetic lozenges
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US8569375B2 (en) * 2008-08-22 2013-10-29 Reckitt Benckiser Healthcare (Uk) Limited Compositions
WO2014196916A1 (en) 2013-06-03 2014-12-11 Mcneil Ab Solid pharmaceutical dosage form for release of at least one active pharmaceutical ingredient in the oral cavity
WO2018144491A1 (en) * 2017-02-01 2018-08-09 Johnson & Johnson Consumer Inc. A lozenge

Also Published As

Publication number Publication date
EP3576718B1 (en) 2021-07-14
US11400047B2 (en) 2022-08-02
ES2881482T3 (es) 2021-11-29
EP3915540A1 (en) 2021-12-01
DK3576718T3 (da) 2021-08-23
WO2018144491A1 (en) 2018-08-09
PL3576718T3 (pl) 2021-12-27
AU2018216886A1 (en) 2019-08-01
EP3576718A1 (en) 2019-12-11
CA3050738A1 (en) 2018-08-09
PT3576718T (pt) 2021-08-06
EA039362B1 (ru) 2022-01-18
US20190358157A1 (en) 2019-11-28
HUE055173T2 (hu) 2021-11-29
US20220323348A1 (en) 2022-10-13
HRP20211247T1 (hr) 2021-11-12
AU2018216886B2 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
CY1124548T1 (el) Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου του δαγκειου ιου
EA201891203A1 (ru) Гетероциклические соединения в качестве иммуномодуляторов
EA201800367A1 (ru) Способы лечения болезни хантингтона
EA201691845A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201990043A1 (ru) Антибактериальные соединения
CY1122792T1 (el) Παραγωγα μονο- ή δισυποκατεστημενης ινδολης ως αναστολεις αναδιπλασιασμου δαγκειου ιου
EA201790271A1 (ru) Ингибиторы гликозидазы
EA201691844A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201790998A1 (ru) Иммуннорегуляторные агенты
EA201692079A1 (ru) Ингибиторы лизин-специфической деметилазы-1
EA201790700A1 (ru) Моно- или дизамещенные индолы в качестве ингибиторов репликации вирусов денге
EA201991073A1 (ru) Ингибиторы magl
EA201992782A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EA201790576A1 (ru) Спироциклические ингибиторы катепсина с
EA201990400A1 (ru) Соединения и композиции и их применение
EA201791907A1 (ru) Бивалентная вакцина против вируса свиного гриппа
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
EA201792008A1 (ru) Соединения азапиридона и способы их применения
EA201891440A1 (ru) Составы/композиции, содержащие ингибитор btk
EA201892203A1 (ru) Оксабороловые сложные эфиры, их применение
EA201991819A1 (ru) Пастилка
EA202090945A1 (ru) Анти-msln-антитело и фармацевтическая композиция для лечения онкологических заболеваний, содержащая его
EA202091112A1 (ru) Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение
EA201890477A1 (ru) Инкапсулированная композиция финголимода
EA202092045A1 (ru) Лечение и предупреждение преэклампсии